pembrolizumab
merck
['head and neck', 'pembro']
pembrolizumab plus chemoradiation therapy (crt) vs placebo plus crt for locally advanced head and neck squamous cell carcinoma did not met primary endpoint of efs in itt population! #esmo22 
Pursuing to improve cancer prevention and care. Medical Oncologist @AnkaraUni